A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer. (Q45158856)
scientific article published on 22 November 2004
Language:
Current Data About A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
(P31) (Q13442814)
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P50) (Q66213999)
(P1545) 1
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P304) 939-952
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P407) (Q1860)

(P433) 5
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P478) 23
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P577) Monday, November 22, 2004
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P921) (Q574834)
(P887)

(P1433) (Q400292)
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P1476) "A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer" (language: en)
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P2093) Douglas Hanahan
(P1545) 2
(P248)
(P698) 15557593
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15557593%20AND%20SRC:MED&resulttype=core&format=json
(P813) Sunday, January 5, 2020

(P2860) (Q35967045)
(P248)
(P813) Friday, April 1, 2022
(P854) https://opencitations.net/index/coci/api/v1/citations/10.1101/GAD.266803

other details
description scientific article published on 22 November 2004

External Links
(P356) 10.1200/JCO.2005.07.093
(P698) 15557593